AbbVie, Biohaven, Teva and Satsuma tackle migraine at AHS R&D, Therapeutics The annual meeting of the American Headache Society (AHS) is being held in Denver, Colorado from June 9-12. Here’s a look at just some of the wide-ranging research being presented. Read more June 9, 2022/by BioSpace https://www.pharmalive.com/wp-content/uploads/2022/06/BioSpaceheadache6-9-2022.jpg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2022-06-09 12:18:162022-06-09 12:25:20AbbVie, Biohaven, Teva and Satsuma tackle migraine at AHS